Kolon TissueGene (XKRX:950160) Days Sales Outstanding : 35.73 (As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Kolon TissueGene Days Sales Outstanding?

Kolon TissueGene's average Accounts Receivable for the three months ended in Dec. 2024 was ₩305 Mil. Kolon TissueGene's Revenue for the three months ended in Dec. 2024 was ₩779 Mil. Hence, Kolon TissueGene's Days Sales Outstanding for the three months ended in Dec. 2024 was 35.73.

The historical rank and industry rank for Kolon TissueGene's Days Sales Outstanding or its related term are showing as below:

XKRX:950160' s Days Sales Outstanding Range Over the Past 10 Years
Min: 7.1 Med: 51.45 Max: 83.47
Current: 17.3

During the past 9 years, Kolon TissueGene's highest Days Sales Outstanding was 83.47. The lowest was 7.10. And the median was 51.45.

XKRX:950160's Days Sales Outstanding is ranked better than
91.12% of 845 companies
in the Biotechnology industry
Industry Median: 69.43 vs XKRX:950160: 17.30

Kolon TissueGene's Days Sales Outstanding increased from Dec. 2023 (31.09) to Dec. 2024 (35.73).

Kolon TissueGene Days Sales Outstanding Historical Data

The historical data trend for Kolon TissueGene's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kolon TissueGene Days Sales Outstanding Chart

Kolon TissueGene Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Sales Outstanding

Get a 7-Day Free Trial

73.07

41.85

7.10

10.70

15.16

Kolon TissueGene Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Days Sales Outstanding	Get a 7-Day Free Trial															31.09	11.63	19.15	14.12	35.73

Competitive Comparison of Kolon TissueGene's Days Sales Outstanding

For the Biotechnology subindustry, Kolon TissueGene's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kolon TissueGene's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kolon TissueGene's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Kolon TissueGene's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

Kolon TissueGene Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Kolon TissueGene's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

	Days Sales Outstanding (A: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (183.583	+	237.734)	/	2 )	/	5073.437	*	365
=	210.6585					/	5073.437	*	365
=	15.16

Kolon TissueGene's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding (Q: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2024 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (372.351	+	237.734)	/	2 )	/	779.02	*	365 / 4
=	305.0425					/	779.02	*	365 / 4
=	35.73

Kolon TissueGene (XKRX:950160) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Kolon TissueGene Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Kolon TissueGene's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Kolon TissueGene Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kolon TissueGene Inc (XKRX:950160) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

9713 Key West Avenue, Suite 300, Rockville, MD, USA, 20850

Website

https://www.tissuegene.com

Kolon TissueGene Inc is a biopharmaceutical company that develops regenerative therapies for the treatment of various orthopedic disorders. It is developing four product candidates, TG-C, TG-B, TG-D and TG-N for regeneration of cartilage, bone, disc and nerve.

Kolon TissueGene Headlines

No Headlines